US Broker Ratings

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Giant with a 24.74% Potential Upside Awaits Investor Attention

Ascendis Pharma A/S (NASDAQ: ASND), a key player in the biotechnology sector, continues to capture the interest of investors with its innovative approach to treating unmet..

Revolution Medicines, Inc. (RVMD) Investor Outlook: A Promising 41.72% Upside Potential Amidst Strong Buy Consensus

Revolution Medicines, Inc. (NASDAQ: RVMD) is garnering significant attention from investors, particularly those with an eye for high-growth potential in the biotechnology sector. Specializing in precision..

Labcorp Holdings Inc. (LH) Stock Analysis: Navigating Growth in the Diagnostics Sector with a 7.34% Potential Upside

Labcorp Holdings Inc. (NYSE: LH), a key player in the healthcare sector specializing in diagnostics and research, continues to capture the attention of investors with its..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Evaluating 2.30% Upside Amid Healthcare Sector Dynamics

Smith & Nephew SNATS, Inc. (SNN), a stalwart in the healthcare sector, continues to capture the attention of investors as it navigates the complex medical devices..

Chemed Corp (CHE) Stock Analysis: Exploring a 32.5% Potential Upside and Strong Buy Ratings

For investors eyeing opportunities in the healthcare sector, Chemed Corp (NYSE: CHE) presents a compelling case. The company, headquartered in Cincinnati, Ohio, is a significant player..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 25% Upside with Robust Analyst Support

Alcon Inc. (NYSE: ALC), a leading player in the global eye care industry, offers a compelling investment opportunity with a potential upside of 25.04%, according to..

Verona Pharma plc (VRNA) Stock Analysis: A Healthcare Contender at Its 52-Week High

Verona Pharma plc (NASDAQ: VRNA) has captured investor attention as it recently hit its 52-week high of $106.91, marking a significant milestone for this UK-based biopharmaceutical..

DexCom, Inc. (DXCM) Investor Outlook: Key Insights on a 39.91% Potential Upside

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector specializing in medical devices, is capturing investor attention with its innovative continuous glucose monitoring (CGM) systems...

Repligen Corporation (RGEN) Stock Analysis: A Healthcare Gem with 8.42% Upside Potential

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector as a dynamic player in the medical instruments and supplies industry. With a market capitalization of..

Zoetis Inc. (ZTS) Stock Analysis: Evaluating a 28.61% Potential Upside in Animal Health

Zoetis Inc. (NYSE: ZTS), a prominent player in the animal health industry, presents a compelling proposition for investors seeking growth opportunities within the healthcare sector. As..

BioNTech SE (BNTX) Stock Analysis: A 27.62% Potential Upside Amid Robust Revenue Growth

BioNTech SE (NASDAQ: BNTX), a pivotal player in the biotechnology sector, is drawing significant investor attention with its notable 27.62% potential upside, as suggested by the..

Align Technology, Inc. (ALGN) Stock Analysis: Evaluating a 29% Potential Upside in Healthcare Innovation

Align Technology, Inc. (NASDAQ: ALGN) stands as a significant player in the healthcare sector, specializing in medical instruments and supplies. Headquartered in Tempe, Arizona, Align Technology..

Eli Lilly and Company (LLY) Stock Analysis: Navigating a $739.98 Billion Market Cap with Impressive Revenue Growth

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, is making waves with its impressive market capitalization of $739.98 billion. Operating within the..

Natera, Inc. (NTRA) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Natera, Inc. (NASDAQ: NTRA) is making significant strides in the healthcare sector, specifically in diagnostics and research. As a frontrunner in molecular testing services, Natera’s innovative..

Masimo Corporation (MASI) Stock Analysis: Exploring a 26.93% Potential Upside in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, has caught the attention of investors with its substantial potential upside of 26.93%. As a..

Molina Healthcare Inc (MOH) Investor Outlook: Unpacking Growth Potential Amidst Market Volatility

As Molina Healthcare Inc (NYSE: MOH) navigates the intricacies of the healthcare sector, its current financial standing offers a compelling narrative for investors looking for growth..

Baxter International Inc. (BAX) Stock Analysis: Evaluating a 21.63% Upside Potential in the Healthcare Sector

Baxter International Inc. (BAX), a key player in the healthcare sector, offers a compelling investment opportunity with a potential upside of 21.63%. The company, headquartered in..

Qiagen N.V. (QGEN) Investor Outlook: Analyzing the 4.71% Potential Upside in the Diagnostics & Research Sector

For investors exploring opportunities in the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) presents a compelling case, particularly in the diagnostics and research industry. Headquartered in Venlo,..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 15% Potential Upside Amidst Robust Neurological Pipeline

Biogen Inc. (NASDAQ: BIIB), a titan in the healthcare sector, stands at a pivotal juncture with a market capitalization of $21.98 billion. Specializing in neurological and..

STERIS plc (STE) Stock Analysis: A 13% Upside Beckons for Healthcare Investors

For investors eyeing the healthcare sector, STERIS plc (NYSE: STE) presents a compelling opportunity with a potential upside of 13.13% based on current analyst price targets...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds